AGBL5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.609000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.007400E-01
Normal-vs-Stage2
8.593400E-01
Normal-vs-Stage3
7.232200E-02
Normal-vs-Stage4
4.026000E-01
Stage1-vs-Stage2
9.506600E-01
Stage1-vs-Stage3
1.736010E-01
Stage1-vs-Stage4
3.361600E-01
Stage2-vs-Stage3
1.230410E-01
Stage2-vs-Stage4
1.888990E-01
Stage3-vs-Stage4
4.384400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.798800E-01
Normal-vs-AfricanAmerican
8.447400E-01
Normal-vs-Asian
5.240000E-01
Caucasian-vs-AfricanAmerican
5.662600E-01
Caucasian-vs-Asian
5.794600E-01
AfricanAmerican-vs-Asian
3.729800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.320000E-01
Normal-vs-Female
9.013800E-01
Male-vs-Female
8.105400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.479980E-01
Normal-vs-Age(41-60Yrs)
9.188800E-01
Normal-vs-Age(61-80Yrs)
6.982000E-01
Normal-vs-Age(81-100Yrs)
6.652800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.188400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.005600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.847800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.607800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.932600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.941500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.537400E-01
Normal-vs-Daily Drinker
9.797000E-01
Normal-vs-Weekly Drinker
9.623400E-01
Normal-vs-Occasional Drinker
7.110400E-01
Normal-vs-Social Drinker
8.473600E-01
Non Drinker-vs-Daily Drinker
2.965200E-01
Non Drinker-vs-Weekly Drinker
3.546400E-01
Non Drinker-vs-Occasional Drinker
6.064400E-02
Non Drinker-vs-Social Drinker
1.618990E-01
Daily Drinker-vs-Weekly Drinker
9.736000E-01
Daily Drinker-vs-Occasional Drinker
5.075200E-01
Daily Drinker-vs-Social Drinker
6.878000E-01
Weekly Drinker-vs-Occasional Drinker
5.026800E-01
Weekly Drinker-vs-Social Drinker
6.874400E-01
Occasional Drinker-vs-Social Drinker
8.649200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.923800E-01
Normal-vs-Grade 2
2.420000E-01
Normal-vs-Grade 3
1.950210E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.780000E-01
Grade 1-vs-Grade 3
9.101700E-02
Grade 1-vs-Grade 4
3.923800E-01
Grade 2-vs-Grade 3
1.071410E-01
Grade 2-vs-Grade 4
2.420000E-01
Grade 3-vs-Grade 4
1.950210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.048800E-01
Normal-vs-NonDiabetic
9.481200E-01
Diabetic-vs-NonDiabetic
3.096800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.515000E-01
Normal-vs-NoPancreatitis
7.563000E-01
Pancreatitis-vs-NoPancreatitis
1.394190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.028200E-01
Normal-vs-N1
8.549200E-01
N0-vs-N1
9.064800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.642400E-01
Normal-vs-TP53-NonMutant
8.283600E-01
TP53-Mutant-vs-TP53-NonMutant
2.569700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
